Shares of Ventas, Inc. (NYSE:VTR – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nineteen analysts that are presently covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $96.1667.
A number of brokerages have recently issued reports on VTR. Mizuho set a $98.00 price target on Ventas in a research report on Friday, May 22nd. UBS Group boosted their target price on Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research note on Monday, May 4th. Royal Bank Of Canada upped their target price on Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $100.00 price target on shares of Ventas in a research note on Tuesday, June 16th. Finally, Scotiabank lowered their price target on Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a report on Thursday, June 18th.
View Our Latest Analysis on VTR
Insider Buying and Selling
Institutional Trading of Ventas
Several large investors have recently added to or reduced their stakes in VTR. Dynamic Wealth Strategies LLC acquired a new stake in shares of Ventas during the first quarter worth about $25,000. GoalVest Advisory LLC acquired a new stake in Ventas during the 4th quarter valued at approximately $26,000. Wiser Advisor Group LLC acquired a new stake in Ventas during the 3rd quarter valued at approximately $27,000. IFC & Insurance Marketing Inc. purchased a new stake in shares of Ventas in the 4th quarter valued at $30,000. Finally, Elyxium Wealth LLC purchased a new stake in shares of Ventas in the 4th quarter valued at $33,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.
Ventas Stock Performance
VTR stock opened at $90.61 on Monday. The firm has a market cap of $44.05 billion, a price-to-earnings ratio of 164.75, a PEG ratio of 1.95 and a beta of 0.70. The firm has a 50-day simple moving average of $86.61 and a two-hundred day simple moving average of $83.69. Ventas has a one year low of $62.82 and a one year high of $94.60. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25.
Ventas (NYSE:VTR – Get Free Report) last issued its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The firm’s quarterly revenue was up 22.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities analysts forecast that Ventas will post 3.88 EPS for the current fiscal year.
Ventas Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be paid a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.3%. Ventas’s dividend payout ratio (DPR) is 378.18%.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Articles
- Five stocks we like better than Ventas
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
